When Should Tramadol Be Avoided?

📧 EM Note Newsletter https://forms.gle/8boToiKDXVE3V8U19 Signup to get free weekly PDF via email. PS: Please join our membership for more perks (members can request for specific PDF file by posting in the EM Note YouTube Membership section). Homepage: EMNote.org ■ 🚩Membership: https://tinyurl.com/joinemnote 🚩ACLS Lecture: https://tinyurl.com/emnoteacls This lecture provides a detailed pharmacological overview of Tramadol, characterizing it as a "dirty drug" due to its complex, multimodal mechanism of action as both a weak opioid agonist and a serotonin-norepinephrine reuptake inhibitor. A central theme is the drug's metabolism, explaining that Tramadol is a prodrug that relies on the CYP2D6 enzyme for conversion into its active, potent metabolite, which introduces significant risks due to genetic variability among patients classified as poor or ultra-rapid metabolizers. The text asserts that Tramadol’s analgesic efficacy is often inconsistent and equivalent to Codeine, noting it carries unique and serious risks beyond standard opioids, specifically Serotonin Toxicity and Seizures, which are often amplified by drug interactions and metabolic issues. Ultimately, the source concludes that Tramadol is rarely the best initial pain management strategy given its lack of predictable outcomes and complicated safety profile.